Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$177.15
+2.9%
$170.01
$108.35
▼
$182.99
$48.55B1.242.03 million shs2.49 million shs
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$369.70
+3.2%
$371.91
$236.73
▼
$396.23
$9.63B1.06253,293 shs460,472 shs
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$333.47
+0.4%
$314.26
$146.20
▼
$379.63
$15.92B1.361.28 million shs516,497 shs
Bio-Techne Corp stock logo
TECH
Bio-Techne
$72.75
+0.2%
$72.56
$43.19
▼
$72.88
$11.41B1.293.17 million shs2.63 million shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
+2.82%-0.01%+4.26%+13.20%+23.15%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
+3.01%-4.29%+4.96%-1.96%+20.09%
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
+0.23%-2.72%+11.24%+13.82%+104.80%
Bio-Techne Corp stock logo
TECH
Bio-Techne
+0.17%-0.07%+0.36%+0.65%+25.11%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$177.15
+2.9%
$170.01
$108.35
▼
$182.99
$48.55B1.242.03 million shs2.49 million shs
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$369.70
+3.2%
$371.91
$236.73
▼
$396.23
$9.63B1.06253,293 shs460,472 shs
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$333.47
+0.4%
$314.26
$146.20
▼
$379.63
$15.92B1.361.28 million shs516,497 shs
Bio-Techne Corp stock logo
TECH
Bio-Techne
$72.75
+0.2%
$72.56
$43.19
▼
$72.88
$11.41B1.293.17 million shs2.63 million shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
+2.82%-0.01%+4.26%+13.20%+23.15%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
+3.01%-4.29%+4.96%-1.96%+20.09%
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
+0.23%-2.72%+11.24%+13.82%+104.80%
Bio-Techne Corp stock logo
TECH
Bio-Techne
+0.17%-0.07%+0.36%+0.65%+25.11%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
2.82
Moderate Buy$181.452.43% Upside
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
2.20
Hold$366.67-0.82% Downside
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
2.69
Moderate Buy$311.67-6.54% Downside
Bio-Techne Corp stock logo
TECH
Bio-Techne
2.12
Hold$68.92-5.26% Downside

Current Analyst Ratings Breakdown

Latest TECH, A, BIO, and CRL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/11/2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Reiterated RatingBuy$388.00
11/9/2026
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
UpgradeHold (C) ➝ Hold (C+)
11/5/2026
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Boost Price TargetOutperform$390.00 ➝ $440.00
11/5/2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Boost Price TargetBuy$357.00 ➝ $387.00
11/5/2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Boost Price TargetOutperform$322.00 ➝ $352.00
11/5/2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Boost Price TargetOverweight$330.00 ➝ $375.00
11/2/2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
DowngradeStrong-Buy ➝ Hold
10/29/2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
UpgradeHold ➝ Strong-Buy
10/26/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Initiated CoverageBuy$190.00
10/26/2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
DowngradeStrong-Buy ➝ Strong Sell
10/14/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Boost Price Target$190.00 ➝ $195.00
(Data available from 11/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$7.37B6.77$6.82 per share25.97$23.78 per share7.45
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.58B3.85$10.34 per share35.74$282.71 per share1.31
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$3.98B4.02$22.04 per share15.13$67.45 per share4.94
Bio-Techne Corp stock logo
TECH
Bio-Techne
$1.22B9.41$2.35 per share30.94$13.79 per share5.28
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.30B$5.0834.8726.252.5319.53%24.45%13.09%11/23/2026 (Estimated)
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$759.90M$37.979.7440.99N/A39.45%3.58%2.51%N/A
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
-$144.34M$0.91366.4526.013.001.01%16.95%6.93%N/A
Bio-Techne Corp stock logo
TECH
Bio-Techne
$181.86M$1.0941.9836.935.2713.95%13.00%10.57%2/3/2027 (Estimated)

Latest TECH, A, BIO, and CRL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/23/2026Q4 2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.73N/AN/AN/A$1.99 billionN/A
11/9/2026Q1 2027
Bio-Techne Corp stock logo
TECH
Bio-Techne
$0.44$0.44N/A$0.18$292.60 million$299.71 million
11/4/2026Q3 2026
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.23$2.65+$0.42$17.02$649.94 million$656.40 million
11/4/2026Q3 2026
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$2.97$3.09+$0.12$6.86$960.36 million$982.73 million
8/26/2026Q3 2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.49$1.62+$0.13$1.28$1.84 billion$1.88 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.020.58%+6.58%20.08%9 Years
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
N/AN/AN/AN/AN/A
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
N/AN/AN/AN/AN/A
Bio-Techne Corp stock logo
TECH
Bio-Techne
$0.320.44%N/A29.36%N/A

Latest TECH, A, BIO, and CRL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/18/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
quarterly$0.26250.59%1/5/20271/5/20271/27/2027
11/3/2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
quarterly$0.080.44%11/13/202611/13/202611/23/2026
9/16/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
quarterly$0.25500.6%10/6/202610/6/202610/28/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.50
2.05
1.56
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
0.11
3.18
2.37
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
0.76
1.41
1.12
Bio-Techne Corp stock logo
TECH
Bio-Techne
N/A
2.28
1.74

Institutional Ownership

CompanyInstitutional Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
87.41%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
65.24%
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
98.91%
Bio-Techne Corp stock logo
TECH
Bio-Techne
98.95%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
18,100281.93 millionN/AOptionable
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
7,45026.89 million18.73 millionOptionable
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
19,70047.92 million47.29 millionOptionable
Bio-Techne Corp stock logo
TECH
Bio-Techne
3,000157.09 million155.05 millionOptionable

Recent News About These Companies

Bio-Techne Q1 Profit Down
Bio-Techne (NASDAQ:TECH) Issues Earnings Results
Bio-Techne (TECH), What Is Behind The Fresh Attention Now?
Bio-Techne declares $0.08 dividend
BIO-TECHNE DECLARES DIVIDEND

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Agilent Technologies stock logo

Agilent Technologies NYSE:A

$177.15 +4.93 (+2.86%)
Closing price 11/18/2026 03:59 PM Eastern
Extended Trading
$178.16 +1.01 (+0.57%)
As of 04:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Bio-Rad Laboratories stock logo

Bio-Rad Laboratories NYSE:BIO

$369.70 +11.51 (+3.21%)
Closing price 11/18/2026 03:59 PM Eastern
Extended Trading
$370.05 +0.36 (+0.10%)
As of 04:10 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Charles River Laboratories International stock logo

Charles River Laboratories International NYSE:CRL

$333.47 +1.31 (+0.39%)
Closing price 11/18/2026 03:59 PM Eastern
Extended Trading
$338.82 +5.36 (+1.61%)
As of 04:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Bio-Techne stock logo

Bio-Techne NASDAQ:TECH

$72.75 +0.12 (+0.17%)
Closing price 11/18/2026 04:00 PM Eastern
Extended Trading
$72.72 -0.03 (-0.04%)
As of 11/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.